Norditropin SimpleXx 15 mg/1.5 ml ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
3	脊髄性筋萎縮症	1

3. 脊髄性筋萎縮症

---

臨床試験数 : 237 /  薬物数 : 123 - (DrugBank : 29) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 75

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-002822-78-DE (EUCTR)	09/01/2006	21/11/2005	Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III? - SMA-GH	Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III? - SMA-GH	Spinal muscular atrophy (SMA) is an autosomal recessive disease. Due to the genetic defect, a molecule called spinal motor neuron” (SMN) protein is lacking, resulting in muscle weakness. In SMAs muscle weakness is found most often at the level of proximal muscles. The disease is life-threatening and chronically debilitating.	Trade Name: Norditropin SimpleXx Product Name: Norditropin SimpleXx 15 mg/1.5 ml Product Code: GH INN or Proposed INN: Somatropin Other descriptive name: Norditropin SimpleXx	Klinik Neuropädiatrie und Muskelkrankheiten	NULL	Not Recruiting			Female: yes Male: yes	20		Germany